What specific proposal did BioNexus Gene Lab Corp. CEO Sam Tan make to deepen Malaysia–China biotechnology collaboration?

CEO Sam Tan proposed building a Malaysia–China precision healthcare corridor focused on co-development, clinical validation, and broader regional healthcare access — moving beyond traditional trade into joint innovation and implementation.

How does BioNexus Gene Lab Corp. plan to support cross-border commercialization of advanced molecular diagnostics between Malaysia and China?

BioNexus aims to leverage its Nasdaq listing and the Fidelion Diagnostics model to facilitate cross-border commercialization and expand access to advanced molecular diagnostics.

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

May 29, 2026

BioNexus Gene Lab Corp advocated for deeper Malaysia-China biotech collaboration at the 2026 Economic Cooperation Outlook Forum. CEO Sam Tan proposed a precision healthcare corridor to facilitate cross-border commercialization of molecular diagnostics beyond traditional trade.

GlobeNewswire

BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development

GeneOnline

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

The Norfolk Daily News

Show all reports

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

FAQ